Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.581NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.330ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.330ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.330ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.330NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.205ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.205ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.205ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.205NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.177ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.177ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.177ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.177NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.301ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.301ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.301ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.301NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.308ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.308ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.308ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.308NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.210ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.210ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.210ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.210NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.325ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.325ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.325ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.325NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.590ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.590ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.590ENiu-ECACGTTAACAATATTGCAGC20402639126372R-16283.8China
B.1.590NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.116ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.116ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.116ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.116NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.496ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.496ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.496ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.496NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.438.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.438.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.438.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.438.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.49 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.49 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.49 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.49 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FZ.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used